Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis

The Nucleoside Hydrolase (NH36) is the main marker of the FML complex of Leishmania donovani, antigen of the licensed Leishmune® vaccine for prophylaxis of canine visceral leishmaniasis. As a DNA vaccine in mice, it induces a TH1 immune response. We vaccinated mongrel dogs with the VR1012NH36 vaccin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Procedia in vaccinology 2009, Vol.1 (1), p.104-109
Hauptverfasser:	Borja-Cabrera, GP, Santos, FB, Picillo, E, Gravino, AE, Manna, L, Palatnik-de-Sousa, CB
Format:	Artikel
Sprache:	eng
Schlagworte:	Canine visceral leishmaniasis DNA vaccines Immunotherapy Leishmanioses Nucleoside hydrolase Prophylaxis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!